Order Article Reprints

Banoei MM, McIntyre LA, Stewart DJ, Mei SHJ, Courtman D, Watpool I, Granton J, Marshall J, dos Santos C, Walley KR, et al. Metabolomics Analysis of Mesenchymal Stem Cell (MSC) Therapy in a Phase I Clinical Trial of Septic Shock: An Exploratory Study. Metabolites. 2023; 13(11):1142. https://doi.org/10.3390/metabo13111142

Banoei, Mohammad M., Lauralyn A. McIntyre, Duncan J. Stewart, Shirley H. J. Mei, David Courtman, Irene Watpool, John Granton, John Marshall, Claudia dos Santos, Keith R. Walley, and et al. 2023. "Metabolomics Analysis of Mesenchymal Stem Cell (MSC) Therapy in a Phase I Clinical Trial of Septic Shock: An Exploratory Study" Metabolites 13, no. 11: 1142. https://doi.org/10.3390/metabo13111142

Banoei, M. M., McIntyre, L. A., Stewart, D. J., Mei, S. H. J., Courtman, D., Watpool, I., Granton, J., Marshall, J., dos Santos, C., Walley, K. R., Schlosser, K., Fergusson, D. A., Winston, B. W., on behalf of Canadian Critical Care Trials Group (CCCTG), & on behalf of Canadian Critical Care Translational Biology Group (CCCTBG). (2023). Metabolomics Analysis of Mesenchymal Stem Cell (MSC) Therapy in a Phase I Clinical Trial of Septic Shock: An Exploratory Study. Metabolites, 13(11), 1142. https://doi.org/10.3390/metabo13111142